Tabula Rasa HealthCare (TRHC) has announced the completion of sale of its business PrescribeWellness to Transaction Data Systems (TDS), for a purchase price of up to $140m in cash. 

In June this year, TRHC signed a definitive agreement for the sale of its PrescribeWellness business, which provides patient relationship management solutions, to TDS.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

TRHC paid $125m at the closing of the transaction, and up to an additional $15m of the purchase price will be paid if specific performance-based metrics are achieved during the fiscals ending 31 December 2023 and 2024.

Following the sale, TDS is likely to add the PrescribeWellness business to its clinical applications portfolio. This acquisition will support TDS to improve collaboration among pharmacists, clinicians, payers and patients.

As a pharmacy-focused solutions provider, TDS offers a wide range of products and services including Rx30, Computer-Rx, KloudScript, Pharm Assess and Enhanced Medication Services.

It has been working for hassle-free operation of the pharmacy market and pharmacy supply chain since 40 years.

TRHC CEO, chairman and founder Calvin Knowlton said: “The successful sale of PrescribeWellness represents another step forward in our ongoing strategic transformation.

“Through our planned asset divestitures, we are creating a more focused business that is better positioned to capture the significant opportunities ahead in the PACE and broader value-based care market, unlocking long-term value for all TRHC stockholders.”

TRHC provides medication safety solutions. Its technology solutions including MedWise focus on improving patient outcomes, reducing hospitalisations and healthcare costs.

Further, its clinical tele-pharmacy network ensures quality care for patients across the nation.